PEMETAAN WILAYAH PENGIRIMAN PRODUK UNTUK MENDUKUNG E-COMMERCE STOKIS PT.GEMA ENERGI TOTAL DALAM MELAYANI MITRA KERJA

PT. Gema Energi Total (GET) merupakan perusahaan berbasis bisnis multilevel marketing yang sedang berkembang di Indonesia. Proses penyebaran produk saat ini masih menggunakan cara konvensional dengan menggunakan media sosial. PT. GET menerapkan sistem dropship kepada stokis dan member-nya. Penerapan sistem pemetaan wilayah kirim produk untuk mendukung E-Commerce stokis PT. GET dalam melayani mitra kerja bertujuan untuk menyediakan media penjualan dalam internal bisnis PT. GET secara business to business (B2B) yang dapat memudahkan member dalam memesan produk kepada stokis untuk dikirim ke konsumen akhir. Sistem pemetaan wilayah E-Commerce ini dibangun berbasis web dengan menggunakan metode FAST (Framework for the Application of System Techniques), PHP sebagai bahasa pemograman, dan MySQL sebagai DBMS-nya. Dengan adanya repository data transaksi penjualan dan penyebaran produk maka pihak perusahaan dapat memantau langsung penjualan pada tingkat stokis dan member

Human Distance Estimation Using Quadcopter For Surveillance Purpose

Nowadays, quadcopters are commonly used. Quadcopters are unmanned aerial vehicles with four propellers to provide lift to fly and hover above ground. Quadcopter nowadays is a very common commercial item in everyday life. Some quadcopters are designed to do 3D or 2D mapping of a certain area or to take videos or just for entertainment purposes. Quadcopter is a very versatile item and is able to change into anything for example a quadcopter can also be used for security purposes to decrease the crime rate of our country. The objective of this study is to design and develop a quadcopter with image processing system to have the ability to measure the distance of a human from the drone itself. The quadcopter is designed to be small in size and have a mini computer like Raspberry Pi on top of it to compute the algorithm to calculate the distance of the human by using image processing technique through the camera which is setup on the drone. Human detecting algorithm YOLO and software Open CV is chosen to detect human and calculate the distance from the quadcopter. The results show that the system is quite limited by the capabilities of the hardware. The system shows an accuracy of more than 90 percent when the human is standing within a certain range. Both the accuracy of the distance sensing and human recognizing system is affected by the limitation of the hardware

An Analysis Of Sensor Placement For Vehicle's Blind Spot Detection And Warning System

Nowadays, the number of accidents involving motorized vehicles is increasing especially the side collision of the vehicles when the driver attempt to change from one lane to another either to left or right which is due to the carelessness of the driver and unsighted the blind spot. However, the cooperation of technology can overcome this problem. The key element is the ability to detect the incoming vehicle in the blind spot area. However, problems rises when the sensor used for the system only able to cover certain amount of area. The objectives of this study is to develop and implement a device that will warn the driver about the incoming vehicles in the blind spot area by blinking LED and to investigate the effectiveness of the system in terms of the position of the sensor used for the system. The developed system are equipped with an Arduino UNO microcontroller and SRF04 ultrasonic sensor. There are two experiments be conducted. The first experiment is carried out to make an analysis on the time response of the system with position of the sensor above the rear tire of the static vehicle. The second experiment is carried out to examine the time response of the system with same position of the sensor with the moving vehicle at certain constant velocity. The result shows that the sensor placement above the rear tire give a good performance in term of driver notification of the presence of vehicle at the blind spot region

A New Data Glove Approach For Malaysian Sign Language Detection

A normal human being sees, listens, and reacts to his/her surroundings. There are some individuals who do not have this important blessing. Such individuals, mainly deaf and dumb, depend on communication via sign language to interact with others. However, communication with ordinary individuals is a major concern for them since not everyone can comprehend their sign language. Furthermore, this will cause a problem for the deaf and dumb communities to interact with others, particularly when they attempt to involve with educational, social and work environments. In this research, the objectives are to develop a sign language translation system in order to assist the hearing or speech impaired people to communicate with normal people, and also to test the accuracy of the system in interpreting the sign language. As a first step, the best method in gesture recognition was chosen after reviewing previous researches. The configuration of the data glove includes 10 tilt sensors to capture the finger flexion, an accelerometer for recognizing the motion of the hand, a microcontroller and Bluetooth module to send the interpreted information to a mobile phone. Firstly the performance of the tilt sensor was tested. Then after assembling all connections, the accuracy of the data glove in translating some selected alphabets, numbers and words from Malaysian Sign Language is performed. The result for the first experiment shows that tilt sensor need to be tilted more than 85 degree to successfully change the digital state. For the accuracy of 4 individuals who tested this device, total average accuracy for translating alphabets is 95%, numbers is 93.33% and gestures is 78.33%. The average accuracy of data glove for translating all type of gestures is 89%. This fusion of tilt sensors and accelerometer could be improved in the future by adding more training and test data as well as underlying frameworks such as Hidden Markov Model

Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications

We performed a cross-sectional, population-based survey of persons 20 years of age and older living in Cairo and surrounding rural villages. The purpose was to describe glycaemic control and the prevalence of microvascular and neuropathic complications among Egyptians with diagnosed diabetes, previously undiagnosed diabetes, impaired glucose tolerance, and normal glucose tolerance. A total of 6052 households were surveyed. The response rate was 76 % for the household survey and 72 % for the medical examination. Among people with previously diagnosed diabetes, mean haemoglobin A 1c was 9.0 %. Forty-two per cent had retinopathy, 21 % albuminuria, and 22 % neuropathy. Legal blindness was prevalent (5 %) but clinical nephropathy (7 %) and foot ulcers (1 %) were uncommon in persons with diagnosed diabetes. Among people with diagnosed diabetes, microvascular and neuropathic complications were associated with hyperglycaemia. Retinopathy was also associated with duration of diabetes; albuminuria with hypertension and hypercholesterolaemia; and neuropathy with age, female sex, and hypercholesterolaemia. Albuminuria was as common in people with previously undiagnosed diabetes (22 %) as those with diagnosed disease (21 %). Mean haemoglobin A 1c was lower (7.8 %) and retinopathy (16 %) and neuropathy (14 %) were less prevalent in people with previously undiagnosed disease. Ocular conditions, blindness, and neuropathy were prevalent in the non-diabetic population. The microvascular and neuropathic complications of diabetes are a major clinical and public health problem in Egypt. Copyright © 1998 John Wiley & Sons, Ltd.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/34940/1/696_ftp.pd

Burnout among surgeons before and during the SARS-CoV-2 pandemic: an international survey

Background: SARS-CoV-2 pandemic has had many significant impacts within the surgical realm, and surgeons have been obligated to reconsider almost every aspect of daily clinical practice. Methods: This is a cross-sectional study reported in compliance with the CHERRIES guidelines and conducted through an online platform from June 14th to July 15th, 2020. The primary outcome was the burden of burnout during the pandemic indicated by the validated Shirom-Melamed Burnout Measure. Results: Nine hundred fifty-four surgeons completed the survey. The median length of practice was 10 years; 78.2% included were male with a median age of 37 years old, 39.5% were consultants, 68.9% were general surgeons, and 55.7% were affiliated with an academic institution. Overall, there was a significant increase in the mean burnout score during the pandemic; longer years of practice and older age were significantly associated with less burnout. There were significant reductions in the median number of outpatient visits, operated cases, on-call hours, emergency visits, and research work, so, 48.2% of respondents felt that the training resources were insufficient. The majority (81.3%) of respondents reported that their hospitals were included in the management of COVID-19, 66.5% felt their roles had been minimized; 41% were asked to assist in non-surgical medical practices, and 37.6% of respondents were included in COVID-19 management. Conclusions: There was a significant burnout among trainees. Almost all aspects of clinical and research activities were affected with a significant reduction in the volume of research, outpatient clinic visits, surgical procedures, on-call hours, and emergency cases hindering the training. Trial registration: The study was registered on clicaltrials.gov "NCT04433286" on 16/06/2020

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial

Background Post-partum haemorrhage is the leading cause of maternal death worldwide. Early administration of tranexamic acid reduces deaths due to bleeding in trauma patients. We aimed to assess the effects of early administration of tranexamic acid on death, hysterectomy, and other relevant outcomes in women with post-partum haemorrhage. Methods In this randomised, double-blind, placebo-controlled trial, we recruited women aged 16 years and older with a clinical diagnosis of post-partum haemorrhage after a vaginal birth or caesarean section from 193 hospitals in 21 countries. We randomly assigned women to receive either 1 g intravenous tranexamic acid or matching placebo in addition to usual care. If bleeding continued after 30 min, or stopped and restarted within 24 h of the first dose, a second dose of 1 g of tranexamic acid or placebo could be given. Patients were assigned by selection of a numbered treatment pack from a box containing eight numbered packs that were identical apart from the pack number. Participants, care givers, and those assessing outcomes were masked to allocation. We originally planned to enrol 15 000 women with a composite primary endpoint of death from all-causes or hysterectomy within 42 days of giving birth. However, during the trial it became apparent that the decision to conduct a hysterectomy was often made at the same time as randomisation. Although tranexamic acid could influence the risk of death in these cases, it could not affect the risk of hysterectomy. We therefore increased the sample size from 15 000 to 20 000 women in order to estimate the effect of tranexamic acid on the risk of death from post-partum haemorrhage. All analyses were done on an intention-to-treat basis. This trial is registered with ISRCTN76912190 (Dec 8, 2008); ClinicalTrials.gov, number NCT00872469; and PACTR201007000192283. Findings Between March, 2010, and April, 2016, 20 060 women were enrolled and randomly assigned to receive tranexamic acid (n=10 051) or placebo (n=10 009), of whom 10 036 and 9985, respectively, were included in the analysis. Death due to bleeding was significantly reduced in women given tranexamic acid (155 [1·5%] of 10 036 patients vs 191 [1·9%] of 9985 in the placebo group, risk ratio [RR] 0·81, 95% CI 0·65–1·00; p=0·045), especially in women given treatment within 3 h of giving birth (89 [1·2%] in the tranexamic acid group vs 127 [1·7%] in the placebo group, RR 0·69, 95% CI 0·52–0·91; p=0·008). All other causes of death did not differ significantly by group. Hysterectomy was not reduced with tranexamic acid (358 [3·6%] patients in the tranexamic acid group vs 351 [3·5%] in the placebo group, RR 1·02, 95% CI 0·88–1·07; p=0·84). The composite primary endpoint of death from all causes or hysterectomy was not reduced with tranexamic acid (534 [5·3%] deaths or hysterectomies in the tranexamic acid group vs 546 [5·5%] in the placebo group, RR 0·97, 95% CI 0·87-1·09; p=0·65). Adverse events (including thromboembolic events) did not differ significantly in the tranexamic acid versus placebo group. Interpretation Tranexamic acid reduces death due to bleeding in women with post-partum haemorrhage with no adverse effects. When used as a treatment for postpartum haemorrhage, tranexamic acid should be given as soon as possible after bleeding onset. Funding London School of Hygiene & Tropical Medicine, Pfizer, UK Department of Health, Wellcome Trust, and Bill & Melinda Gates Foundation